MARC Record from University of Toronto

LEADER: 01738cam 2200277 a 4500
005 19981124111736.1
008 981124s1995 mdua b f100 0 eng d
050 4 $aRC632.G36$bN3 1995
090 08 $aRC 632 .G36N3 1995$bGERSTM$c1
111 2 $aNational Institutes of Health Technology Assessment Conference$d(1995 :$cBethesda, Md.)
245 10 $aNIH Technology Assessment Conference on Gaucher Disease :$bCurrent Issues in Diagnosis and Treatment : NIH Technology Assessment Conference, February 27-March 1, 1995, Warren Grant Magnuson Clinical Center, Masur Auditorium, National Institutes of Health, Bethesda, Maryland /$csponsored by the National Institute of Mental Health and the NIH Office of Medical Applications of Research ; cosponsored by the National Institute of Child Health and Human Development ... [et al.] ; CME sponsorship by National Institutes of Health, Continuing Medical Education.
246 14 $aGaucher disease
260 $a[Bethesda, Md. :$bThe Institutes,$c1995]
300 $av, 151 p. :$bill. ;$c28 cm.
500 $a"Program and abstracts"--Cover.
504 $aIncludes bibliographical references.
650 2 $aEnzymes$xtherapeutic use$xcongresses.
650 2 $aGaucher's Disease$xcongresses.
650 2 $aGaucher's Disease$xtherapy$xcongresses.
650 0 $aGaucher's disease$xCongresses.
710 2 $aNational Institute of Child Health and Human Development (U.S.)
710 2 $aNational Institute of Mental Health (U.S.)
710 2 $aNational Institutes of Health (U.S.).$bOffice of Medical Applications of Research.
948 $a11/24/1998$b08/06/2001
039 $flc/lc(lc)
949 $aRC632 .G36 N3 1995$wLC$c1$i31761047305776$d6/11/2007$e25/10/2007$lSTACKS$mGERSTEIN$n4$q1$rY$sY$tBOOK$u16/12/1998